Thursday, May 13, 2021

[IAC#RG] New DRDO Drug 2-DG is based on Acharya Balkrishna’s research

I started to dig about this new drug 2-DG, which was launched last week
by DRDO and Dr. Reddy's. This drug is claimed to reduce the oxygen
demand by a body infected with covid-19.

Reading more on this, I found that this is actually based on a research
paper by Acharya Balkrishna et al. of Patanjali Ayurveda. Here is the
original paper published on the aggregator ResearchGate:

https://www.researchgate.net/publication/340332773_Glucose_antimetabolite_2-Deoxy-D-Glucose_and_its_derivative_as_promising_candidates_for_tackling_COVID-19_Insights_derived_from_in_silico_docking_and_molecular_simulations

--
Regards,
Pankaj Jangid

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.